“Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland – the SAKK 95/16 prostate study” (2021) Swiss Medical Weekly, 151(0910), p. w20464. doi:10.4414/smw.2021.20464.